Orphan drug designation, or ODD, is valuable on both a humanitarian and a profitability basis. And this company is seeing shares rally following news that it was granted the designation for the...

To read the full story on AllPennyStocks.com, click here.

Cardiol Therapeutics (TSX:CRDL)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024 Plus de graphiques de la Bourse Cardiol Therapeutics
Cardiol Therapeutics (TSX:CRDL)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024 Plus de graphiques de la Bourse Cardiol Therapeutics